Modern Pediatrics. Ukraine. (2021). 6(118): 44-54. doi 10.15574/SP.2021.118.44
Dorosh O. I.^1,2, Letz Yu. O.³, Melko I. P.^1,4, Tsymbalyuk–Voloshin I. P.¹, Romanyshyn B. S.¹, Lyha O. V.^1,2
1СNE of Lviv regional council «Western Ukrainian Specialized Pediatric Medical Centre», Ukraine
²Danylo Halytsky Lviv National Medical University, Ukraine
³СNE of Lviv regional council «Lviv Regional Phthisiopulmonary Clinical Center», Ukraine
⁴Center for Medical Innovations NOVO, Lviv, Ukraine

For citation: Dorosh O.I., Letz Yu.O., Melko I.P., Tsymbalyuk–Voloshin I.P. et al. (2021). Successful treatment of pulmonary tuberculosis in a child with acute promyelocytic leukemia, on the background of intensive chemotherapy. Modern Pediatrics. Ukraine. 6(118): 44–54. doi 10.15574/SP.2021.118.44.
Article received: Aug 18, 2021. Accepted for publication: Oct 09, 2021.

The predisposition of patients with acute leukemia (АL) to various infectious complications is a well-known fact. The reason is a decrease in immunity due to the underlying disease and due to the use of immunosuppressive cytostatic and radiotherapy. Tuberculosis infections (TIs) are serious and life-threatening complications in patients with malignant hematological disorders and recipients after hematopoietic stem cell transplantation. Verification of tuberculosis (TB) is often delayed among patients with hematooncological diseases due to low suspicion and due to the search for other infectious complications. Those with the involvement of the respiratory system are the most common complications in immunologically compromised patients. In acute leukemia, the TB process may have been underestimated, due to negative tests for mycobacterium tuberculosis (MBT), and patients with neoplasia are often prescribed antibacterial agents such as amikacin and ftorchinolones, which are also effective against TI.
We describe a 10-year-old boy who was diagnosed with pulmonary tuberculosis, a disseminated form complicated by hydrothorax, during induction chemotherapy for acute promyelocytic leukemia (APL). For diagnostic purposes, repeated punctures of the pleural cavity with drainage of pathological effusion and diagnostic and remedial bronchoscopy were performed, bacterial pneumonia and systemic mycosis were suspected. The diagnosis of TB was verified on the basis of positive PCR test for TB, molecular genetic study of sputum, bronchial lavage for the presence of genome of MBT without resistance to rifampicin, sputum microscopy, while sputum culture and pleural fluid were negative for MBT. TB treatment was coEadministered with AML-BFM 2004 intensive cytostatic therapy without dose reduction of cytostatics. The child was prescribed intensive tuberculostatic therapy with 4 drugs (rifampicin + isoniazid + pyrazinamide + inbutol) for 3 months and subsequent maintenance antituberculous chemotherapy with two drugs for 4 months (rifampicin + isonimazide).
With this analysis, we advocate the need for early suspicion of TB in patients receiving treatment for AL. The results of our study suggest that antitumor chemotherapy is not an obstacle to effective TB-treatment. The described patient is in remission of AML and TB for 21 months.
The research was carried out in accordance with the principles of the Helsinki declaration. The informed consent of the patient was obtained for conducting the studies.
No conflict of interest was declared by the authors.
Key words: acute promyelocytic leukemia, tuberculosis, cytostatic therapy, children.

REFERENCES

1. Adzic T. (2004). Pulmonary tuberculosis in patients with hematological malignancies. Med Pregl. 57: 65-68.

2. Al-Anazi KA, Al-Jasser AM, Evans DAP. (2007). Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study. Ann Clin Microbiol Antimicrob. 6: 16. https://doi.org/10.1186/1476-0711-6-16; PMid:18021401 PMCid:PMC2200647

3. Aljurf M, Gyger M, Alrajhi A, Sahovic E, Chaudhri N, Musa M, Ayoub O, Seth P, Aslam M, Al-Fiar F. (1999). Mycobactrium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant. 24: 551-554. https://doi.org/10.1038/sj.bmt.1701930; PMid:10482941

4. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. (2005). American Thoracic Society. Centers for Disease Control and Prevention. Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med. 172 (9): 1169-1227. https://doi.org/10.1164/rccm.2508001; PMid:16249321

5. Arslan O, Gurman G, Dilek I, Ozcan M, Koc H, Ilhan O, Okan H, Konuk N, Uysal A, Beksac M. (1998). Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey. Haematologia (Budap). 29: 59-62.

6. Askoy DY, Turker A, Altundag MK, Abali H, Durusu M, Erman M, Unar A, Sungur AA, Unal S, Uzun O. (2003). Concomitant Mycobacterium tuberculosis and Aspergillus niger infection in a patient with acute myeloid leukemia. Chemotherapy. 49: 264-266. https://doi.org/10.1159/000072452; PMid:14504439

7. Budak-Alpdogan T, Tangun Y, Kalayoglu-Besisik S, Ratip S, Akan H, Baslar Z, Soysal T, Bayik LA, Koc H. (2000). The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant. 6: 370-374. https://doi.org/10.1016/S1083-8791(00)70013-9

8. Creutzig U, Ritter J, Zimmermann M et al. (2001). Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93. J Clin Oncol. 19: 2705-2713. https://doi.org/10.1200/JCO.2001.19.10.2705; PMid:11352963

9. Cuellar L, Castaneda CA, Rojas K, Flores C, Dolores-Cerna K, Castillo M, Vicente W. (2015). Clinical features and toxicity of tuberculosis treatment in patients with cancer. Rev Peru Med Exp Salud Publica. 32 (2): 272-277. https://doi.org/10.17843/rpmesp.2015.322.1619; PMid:26338386

10. Datta M, Swaminathan S. (2001). Global aspects of tuberculosis in children. Pediatr Resp Rev. 2: 91-96. https://doi.org/10.1053/prrv.2000.0115; PMid:12531054

11. David S, Mathews V. (2018). Mechanisms and management of coagulopathy in acute promyelocytic leukemia. Thromb Res. 164 (1): S82-S88. https://doi.org/10.1016/j.thromres.2018.01.041; PMid:29703489

12. De Braekeleer E, Douet-Guilbert N, De Braekeleer M. (2014). RARA fusion genes in acute promyelocytic leukemia: a review. Expert Rev Hematol. 7 (3): 347-357. https://doi.org/10.1586/17474086.2014.903794; PMid:24720386

13. Delacourt C, Mani TM, Bonnerot V et al. (1993). Computed tomography with normal chest radiograph in tuberculous infection. Arch Dis Child. 69: 430-432. https://doi.org/10.1136/adc.69.4.430; PMid:8259872 PMCid:PMC1029549

14. Delacourt C, Poveda JD, Chureau C et al. (1995). Use of polymerase chain reaction for improved diagnosis of tuberculosis in children. J Pediatr. 126: 703-709. https://doi.org/10.1016/S0022-3476(95)70396-9

15. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. (1999). Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 282 (7): 677-686. https://doi.org/10.1001/jama.282.7.677; PMid:10517722

16. Fusegawa H, Miyachi H, Ohshima T, Arimori S, Ando Y. (1992). Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in blood diseases. Rinsho Ketsueki. 33: 418-422.

17. Gomez-Pastrana D, Torronteras R, Caro P et al. (1999). Diagnosis of tuberculosis in children using a polymerase chain reaction. Pediatr Pulmonol. 28: 344-351. https://doi.org/10.1002/(SICI)1099-0496(199911)28:5<344::AID-PPUL6>3.0.CO;2-D

18. Gurnari C, Voso MT, Girardi K, Mastronuzzi A, Strocchio L. (2021). Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy. Int J Mol Sci. 22 (2): 642. https://doi.org/10.3390/ijms22020642; PMid:33440683 PMCid:PMC7826974

19. Horsburgh CRJr. (2004). Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 350 (20): 2. https://doi.org/10.1056/NEJMsa031667; PMid:15141044

20. Iuldasheva NE, Karachunskii MA, Pivnik AV. (2004). Clinical picture of tuberculosis with concomitant hemoblastoses. Ter Arkh. 76: 49-51.

21. Iuldashiva NE, Karachunskii MA, Pivnik AV. (2002). Various approaches to tuberculosis diagnosis in patients with hemoblastosis. Ter Arkh. 74: 35-38.

22. Jagarlamundi R, Kumar L, Kochupillai V et al. (2000). Infections in acute leukemia: an analysis of 240 febrile episodes. Med Oncol. 17: 111-116. https://doi.org/10.1007/BF02796205; PMid:10871816

23. Karnak D, Kayacan O, Beder S. (2002). Reactivation of pulmonary tuberculosis in malignancy. Tumori. 88: 251-254. https://doi.org/10.1177/030089160208800313; PMid:12195766

24. Kindler T, Schindel C, Brass U, Fischer T. (2001). Fatal sepsis due to mycobacterium tuberculosis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 27: 217-218. https://doi.org/10.1038/sj.bmt.1702737; PMid:11281394

25. Klossek A, Dannenberg C, Feuerhahn MR, Korholz D. (2004). Pulmonary tuberculosis in a child receiving intensive chemotherapy for acute myeloblastic leukemia. J Pediatr Hematol Oncol. 26 (1): 64-67. https://doi.org/10.1097/00043426-200401000-00019; PMid:14707718

26. Lancioni C, LaBeaud AD, Esper F, Abughali N, Auletta J. (2009). Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia. Pediatr Blood Cancer. 53 (7): 1318-1320. https://doi.org/10.1002/pbc.22155; PMid:19618457

27. Lee DG, Choi JH, Kim YJ, Lee S, Min CK, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. (2001). Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia. Int J Hematol. 73: 119-121. https://doi.org/10.1007/BF02981913; PMid:11372747

28. Libshitz HI, Pannu HK, Elting LS, Cooksley CD. (1997). Tuberculosis in cancer patients: an update. J Thorac Imaging. 12: 41-46. https://doi.org/10.1097/00005382-199701000-00006; PMid:8989758

29. Maeda T, Kusumi E, Kami M, Kawabata M, Le Pavoux A, Hara S, Chizuka A, Murashige N, Tanimoto TE, Matsumara T, Yuji K, Yuji K, Wake A, Miyakoshi S, Morinaga S, Taniguchi S, Tokyo Stem Cell Transplant (SCT) Consortium. (2005). Disseminated tuberculosis following reducedintensity cord blood transplantation for patients with hematological diseases. Bone Marrow Transplant. 35: 310-321. https://doi.org/10.1038/sj.bmt.1704824

30. Mattson JC. (2000). Acute promyelocytic leukemia. From morphology to molecular lesions. Clin Lab Med. 20 (1): 83-103. https://doi.org/10.1016/S0272-2712(18)30078-7

31. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. (2010). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection. United States. MMWR Recomm Rep. 59 (5): 1-25.

32. Menon BS, Maziah W, Aiyar S, Zainul F, Shuaib I, Noh L. (2001). Disseminated tuberculosis in acute leukemia. Pediatr Int. 43 (2): 161-163. https://doi.org/10.1046/j.1442-200x.2001.01354.x; PMid:11285069

33. Ministry of Health of Ukraine. (2020). On approval of health standards for tuberculosis. Order of the Ministry of Health of Ukraine of February 25, 2020 No. 530. URL: https://phc.org.ua/sites/default/files/users/user90/Nakaz_MOZ_vid_25.02.2020_530_Standarty_medopomogy_pry_TB.pdf.

34. Mishra P, Kumar R, Mahapatra M, Sharma S, Dixit A, Chaterjee T et al. (2006). Tuberculosis in acute leukemia: a clinico-hematological profile. Hematology. 11 (5): 335-340. https://doi.org/10.1080/10245330600915818; PMid:17607583

35. Misonou J, Kikuchi Y, Aizawa M, Fukuhara T, Hirano T, Kobayashi M, Morioka M, Takemori N, Sakurada K, Miyazaki T. (1987). An autopsy case of severe miliary tuberculosis in a patient with acute lymphoblastic leukemia (ALL). Gan No Rinsho. 33: 703-713.

36. Neu N, Saiman L, San Gabriel P et al. (1999). Diagnosis of pediatric tuberculosis in the modern era. Pediatr Infect Dis J. 18: 122-126. https://doi.org/10.1097/00006454-199902000-00008; PMid:10048683

37. Orfali N, O'Donovan TR, Cahill MR, Benjamin D, Nanus DM, McKenna SL, Gudas LJ, Mongan NP. (2020). All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL). Eur J Haematol. 104 (3): 236-250. https://doi.org/10.1111/ejh.13367; PMid:31811682

38. Pierre C, Olivier C, Lecossier D et al. (1993). Diagnosis of primary tuberculosis in children by amplification and detection of mycobacteria DNA. Am Rev Respir Dis. 147: 420-424. https://doi.org/10.1164/ajrccm/147.2.420; PMid:8430968

39. Pomputius WF 3rd, Rost J, Dennehy PH et al. (1997). Standardization of gastric aspirate technique improves yield in the diagnosis of tuberculosis in children. Pediatr Infect Dis J. 16: 222-226. https://doi.org/10.1097/00006454-199702000-00011; PMid:9041605

40. Ravandi F, Stone R. (2017). Acute Promyelocytic Leukemia: A Perspective. Clin Lymphoma Myeloma Leuk. 17 (9): 543-544. https://doi.org/10.1016/j.clml.2017.06.037; PMid:28735889

41. Sahn SA, Lakshminarayan S. (1976). Tuberculosis after corticosteroid therapy. Br J Dis Chest. 70: 195-205. https://doi.org/10.1016/0007-0971(76)90029-2

42. Saltoglu N, Tasova Y, Midikli D, Aksu HS, Sanli A, Dundar IH. (2004). Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect. 48: 81-85. https://doi.org/10.1016/j.jinf.2003.08.006; PMid:14667795

43. Stefan DC, Kruis AL, Schaaf HS, Wessels G. (2008). Tuberculosis in oncology patients. Ann Trop Paediatr. 28 (2): 111-116. https://doi.org/10.1179/146532808X302125; PMid:18510820

44. Su WJ, Huang CY, Huang CY et al. (2001). Utility of PCR assays for rapid diagnosis of BCG infection in children. Int J Tuberc Lung Dis. 5: 380-384.

45. Teleman MD, Chee CB. Earnest A et al. (2002). Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore. Int J Tuberc Lung Dis. 6: 699-705.

46. Valerio G, Bracciale P, Manisco V, Quitadamo M, Legari G, Bellanova S. (2003). Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results. J Chemother. 15: 66-70. https://doi.org/10.1179/joc.2003.15.1.66; PMid:12678417

47. Waecker NJ, Stefanova R, Cave MD et al. (2000). Nosocomial transmission of Mycobacterium bovis bacille Calmette-Guerin to children receiving cancer therapy and to their health care providers. Clin Infect Dis. 30: 356-362. https://doi.org/10.1086/313652; PMid:10671341

48. Weiser MA, O'Brien S, Escalante C et al. (1999). Tuberculosis meningitis in a patient with acute myelogenous leukemia. Leuk Lymphoma. 33: 187-192. https://doi.org/10.3109/10428199909093741; PMid:10194137

49. Yee D, Valiquette C, Pelletier M et al. (2003). Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 167: 1472-1477. https://doi.org/10.1164/rccm.200206-626OC; PMid:12569078

50. Zhang J, Handorf C. (2004). Miliary tuberculosis presenting as acute respiratory distress syndrome, septic shock, DIC and multiorgan failure. Tenn Med. 97: 164-166.